tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Similar Stocks

Compare
1,524 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$21.56
$15.29B
185.94%
11 Buy
0 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$57.48
$10.86B
21.11
-30.70%
15 Buy
5 Hold
0 Sell
Strong Buy
Exelixis
$42.52
$11.73B
19.47
92.14%
10 Buy
6 Hold
0 Sell
Moderate Buy
Incyte
$70.07
$13.31B
216.24
17.80%
6 Buy
12 Hold
1 Sell
Moderate Buy
United Therapeutics
$328.40
$14.70B
13.11
2.03%
7 Buy
3 Hold
0 Sell
Moderate Buy
Genmab
$22.25
$13.57B
12.49
-16.40%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
21.56
14.02
185.94%
BMRN
BioMarin Pharmaceutical
57.48
-26.39
-31.47%
EXEL
Exelixis
42.52
20.49
93.01%
INCY
Incyte
70.07
10.59
17.80%
UTHR
United Therapeutics
281.36
5.60
2.03%
GMAB
Genmab
22.84
-4.48
-16.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis